Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Shimazaki

Showing results (41-50 of 189) with videos related to

Pageof 19
Sort By:
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|November 1, 1984
[Triploid clone observed in the blastic phase of chronic myelogenous leukemia--DNA cytofluorometry]C Shimazaki, I Omori, A Nishio, et al.
Progress in Clinical and Biological Research|January 1, 1990
Elimination of clonogenic leukemic cells from bone marrow using monoclonal antibodies and magnetic immunobeadsS Murakami, C Shimazaki, N Oku, et al.
Transplantation|March 15, 1996
Pure red cell aplasia induced by FK506S Suzuki, Y Osaka, I Nakai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1981
[Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)]C Shimazaki, Y Nakajima, Y Ura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1985
[Acute leukemia with different cytochemical findings in bone marrow and lymph node]I Omori, C Shimazaki, A Nishio, et al.
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.
Cytotherapy|October 20, 2006
Expression and role of MHC class I-related chain in myeloma cellsM Okamoto, T Inaba, N Yamada, et al.
Leukemia|April 15, 2005
High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiationC Shimazaki, R Uchida, S Nakano, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasmsH Hirai, E Satoh, M Osawa, et al.
Acta Haematologica|January 1, 1992
Novel type of clonally involved cytoplasmic immunoglobulin-negative cells in multiple myeloma: flow cytometric studyC Shimazaki, H Gotoh, N Oku, et al.
Pageof 19

Showing results (41-50 of 189) with videos related to

Sort By:
Pageof 19
Nihon Ketsueki Gakkai Zasshi : Journal of Japan Haematological Society|November 1, 1984
[Triploid clone observed in the blastic phase of chronic myelogenous leukemia--DNA cytofluorometry]C Shimazaki, I Omori, A Nishio, et al.
Progress in Clinical and Biological Research|January 1, 1990
Elimination of clonogenic leukemic cells from bone marrow using monoclonal antibodies and magnetic immunobeadsS Murakami, C Shimazaki, N Oku, et al.
Transplantation|March 15, 1996
Pure red cell aplasia induced by FK506S Suzuki, Y Osaka, I Nakai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|July 1, 1981
[Remission induction by ACM-A and BH-AC on acute promyelocytic leukemia which is resistant to DNR and CA (author's transl)]C Shimazaki, Y Nakajima, Y Ura, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 1, 1985
[Acute leukemia with different cytochemical findings in bone marrow and lymph node]I Omori, C Shimazaki, A Nishio, et al.
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.
Cytotherapy|October 20, 2006
Expression and role of MHC class I-related chain in myeloma cellsM Okamoto, T Inaba, N Yamada, et al.
Leukemia|April 15, 2005
High serum bone-specific alkaline phosphatase level after bortezomib-combined therapy in refractory multiple myeloma: possible role of bortezomib on osteoblast differentiationC Shimazaki, R Uchida, S Nakano, et al.
Biochemical and Biophysical Research Communications|February 12, 1998
Use of EBV-based Vector/HVJ-liposome complex vector for targeted gene therapy of EBV-associated neoplasmsH Hirai, E Satoh, M Osawa, et al.
Acta Haematologica|January 1, 1992
Novel type of clonally involved cytoplasmic immunoglobulin-negative cells in multiple myeloma: flow cytometric studyC Shimazaki, H Gotoh, N Oku, et al.
Pageof 19